Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ymc
    Senior Member
    • Mar 2010
    • 496

    How to estimate tumor purity?

    Typically, tumor samples contain normal cells to a certain extent. Some programs that deal with somatic mutations take tumor purity percentage as an input, e.g. ExomeCNV, VarScan, etc.

    I noticed that ExomeCNV's LOH calling algorithm supposedly can be used to estimate the % contaminated by normal cells. But it is not well documented in their User Guide. Can anyone show me how to do this?

    Or are there other programs that can estimate tumor purity?

    Thanks in advance.
  • chrisamiller
    Junior Member
    • Jun 2008
    • 7

    #2
    Succinctly, you expect heterozygous somatic SNVs to be present in a sample at a frequency around 50% (and homozygous changes to be present at 100%). If your tumor is impure, these fractions will drop. If your sample is 10% normal cells, your numbers would be 45% and 90%. Regions with LOH or single copy number loss provide larger numbers of somatic mutations that should occur at nearly 100%, making this estimation easier.

    Comment

    • davidblaney
      Member
      • Nov 2011
      • 18

      #3
      Is this what you are looking for?

      Comment

      • ymc
        Senior Member
        • Mar 2010
        • 496

        #4
        Originally posted by davidblaney View Post
        Is this what you are looking for?

        http://genomebiology.com/2013/14/7/R80/abstract
        looks good. Thanks a lot!

        Comment

        • ymc
          Senior Member
          • Mar 2010
          • 496

          #5
          This is the function in ExomeCNV to estimate fraction of normal cells in tumor sample. It takes two arguments. The first one is the logR (aka log intensity) value vector for different regions indexed from 1 to length(logR). The second argument is a vector of indexes of the logR vector that is determined to be LOH.

          ========================================
          guesstimate.contamination <-
          function(logR, region.idx=NULL) {
          if (is.null(region.idx)) region.idx = 1:length(logR)
          med.logR = median(logR[region.idx], na.rm=TRUE)
          if (med.logR < 0) { rho = 0.5 } else { rho = 1.5 }
          return((2**med.logR - rho)/(1 - rho))
          }
          =====================================

          From the look of it, it takes the median of the logR values in LOH regions and then apply this formula

          let logR_m be the logR median among the LOH regions

          if logR_m >=0, contamination = 3 - 2^(logR_m + 1)
          if logR_m < 0, contamination = 2^(logR_m + 1) - 1

          It seems to me it is theoretically possible to have contamination to be outside the bound of 0 and 1. Do you think this function is correct?

          Comment

          • ymc
            Senior Member
            • Mar 2010
            • 496

            #6
            According to formula described in their paper, the estimation formula is

            c = 1 - 2*average(|BAF_LOH - 0.5|)



            This formula seems to make more sense. It also won't make c goes out of bound.

            So which formula is correct???

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 11:41 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...